Reuters logo
BRIEF-Corvus Pharmaceuticals reports third quarter 2017 financial results
November 2, 2017 / 9:17 PM / 18 days ago

BRIEF-Corvus Pharmaceuticals reports third quarter 2017 financial results

Nov 2 (Reuters) - Corvus Pharmaceuticals Inc:

* Corvus Pharmaceuticals reports third quarter 2017 financial results and clinical program update

* Net loss for three months ended September 30, 2017, was $12.7 million compared to $10.3 million for same period in 2016​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below